ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
61 100,76
0,50%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Concert Pharmaceuticals Inc (CNCE)

  7. Concert Pharmaceuticals Inc (CNCE) Actualités

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CNCE
DateHeureSourceTitreSymboleSociété
16/03/202314h02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202311h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202317h58Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202317h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202315h47Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202315h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202315h01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202313h00Business WireConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202323h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
13/02/202315h26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/02/202314h12Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/02/202313h32Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CNCEConcert Pharmaceuticals Inc
01/02/202323h13Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202316h40Dow Jones NewsConcert Pharmaceuticals Shares Rally on Takeover by SunNASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202314h47Dow Jones NewsSun Pharmaceutical to Buy Concert Pharmaceuticals For Initial $576 MillionNASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202314h00Business WireSun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
10/12/202200h25TipRanksJonesTrading Keeps Their Buy Rating on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
22/11/202212h25TipRanksH.C. Wainwright Remains a Buy on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
21/11/202213h00Business WireConcert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair ResearchNASDAQ:CNCEConcert Pharmaceuticals Inc
09/11/202213h00Business WireConcert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
08/11/202212h25TipRanksConcert Pharma (CNCE) Gets a Buy from H.C. WainwrightNASDAQ:CNCEConcert Pharmaceuticals Inc
08/11/202204h25TipRanksConcert Pharma (CNCE) Receives a Buy from JonesTradingNASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202218h05TipRanksConcert Pharma (CNCE) Gets a Buy from JMP SecuritiesNASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202213h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202213h00Business WireConcert Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
31/10/202212h00Business WireConcert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022NASDAQ:CNCEConcert Pharmaceuticals Inc
13/09/202203h05TipRanksJonesTrading Sticks to Their Buy Rating for Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
10/09/202211h30Business WireConcert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV CongressNASDAQ:CNCEConcert Pharmaceuticals Inc
06/09/202213h00Business WireConcert Pharmaceuticals to Present at H.C. Wainwright Global Investment ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
01/09/202213h00Business WireBridges and Landmarks Across the USA Will Illuminate Blue Throughout the Month of September for Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE

Dernières Valeurs Consultées

EU
AFDEC
Agence Francaise de Deve...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés